Skip to Main Content
Skip Nav Destination

Innovations Journals

POLICIES AND PROCESSES

Editorial Office: editor@innovationsjournals.com

The following policies and processes apply to all Innovations Journals.

Innovations Journals adhere to the recommendations of the International Committee of Medical Journal Editors (ICMJE, http://www.icmje.org/) and the Committee for Publication Ethics (COPE, https://publicationethics.org/) guidelines to ensure best practices and ethical standards in the conduct and reporting of research and published material. 

Innovations Journals is dedicated to upholding the integrity of the scientific record. As such, the editorial team follows the appropriate guidance from COPE and ICMJE for handling complaints and appeals, which may include publishing a formal correction notice, retraction, or other expressions of concern. Post-publication discussions should be initiated via email to the editorial office at the address above. 

The Editorial Team screens all manuscript submissions for potential concerns including plagiarism, citation manipulation, data falsifcation/fabrication, and other forms of author misconduct. If concerns are identified at any point in the process, even after an article has been published, the editorial team will follow applicable COPE guidelines to address the concerns with the authors and any others who may be involved. Possible consequences of misconduct may include but are not limited to rejection or retraction of a manuscript.  

AUTHORSHIP POLICY

All authors are asked to independently verify their authorship at the time of submission and answer a series of questions about the manuscript. All authors will receive a copy of the decision letter(s) from the editorial team. Upon acceptance, all authors are required to sign the copyright transfer form.

Only those who meet all four criteria authorship, as defined by ICMJE, should be identified as authors. Contributors who do not meet the criteria for full authorship should be acknowledged (see below, “Acknowledgements”).

The ICMJE criteria for authorship are:

    1. Substantial contributions to the conception or design of the work; or the acquisition, analysis, or interpretation of data for the work; AND

    2. Drafting the work or revising it critically for important intellectual content; AND

    3. Final approval of the version to be published; AND

    4. Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved.

The ICMJE guidelines on authorship are available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/defining-the-role-of-authors-and-contributors.html

Authorship Questionnaire

All authors are required to verify their contribution to the manuscript, disclose sources of support and potential conflicts of interest, and answer the following questions when submitting a manuscript:  

  • Do all authors meet the criteria for authorship per ICMJE guidelines?
  • Are you willing to provide raw data, samples, or other supplemental material upon request?
  • Was this research done according to local/regional/national regulations for ethical research, including adherence to legal requirements and patient consent guidelines?
  • Was approval sought from an Institutional Review Board or Ethical Committee, and is this mentioned in the submitted manuscript?
  • For clinical trials, was approval sought from the sponsor to publish this research?
  • For studies with financial support, has the role of the funder or sponsor been mentioned in the submitted manuscript?

Changes in Authorship

This Journal follows a strict process for handling authorship changes prior to acceptance or during proof corrections. Authorship changes are not possible after an article is published. To request a change in the author order or for removal or addition of authors, the following process must be followed:

    1. An explanation for the change should be submitted to the editors

    2. All authors (including those added or removed) must approve the change in writing

Acknowledgements

Contributors who meet fewer than all 4 of the above criteria for authorship should not be listed as authors, but they should be acknowledged. Examples of activities that alone (without other contributions) do not qualify a contributor for authorship are acquisition of funding; general supervision of a research group or general administrative support; and writing assistance, technical editing, language editing, and proofreading.

Corresponding Author Role

The Journal expects that authors would authorize one of them to correspond with the Journal for all matters related to the manuscript from initial submission to final publication. The corresponding author is the one individual who takes primary responsibility for communication with the Journal during the manuscript submission, peer review, and publication process, and typically ensures that all the Journal’s administrative requirements, such as providing details of authorship, ethics committee approval, clinical trial registration documentation, and gathering conflict of interest forms and statements, are properly completed, although these duties may be delegated to one or more coauthors. The corresponding author should be available throughout the submission and peer review process to respond to editorial queries in a timely way, and should be available after publication to respond to critiques of the work and cooperate with any requests from the Journal for data or additional information should questions about the paper arise after publication.

DISCLOSURE POLICY

All authors must disclose any and all conflicts of interest they may have with publication of the manuscript or an institution or product that is mentioned in the manuscript and/or is important to the outcome of the study presented. Authors should also disclose conflict of interests with products that compete with those mentioned in their manuscript.

All sources of study-related funding must be disclosed along with the grant number and role of the funder or sponsor in the study (i.e., study design, data analysis, manuscript writing, and any other aspect of the study).

Authors should confirm if the funder(s) require any specific wording to be included in the published manuscript, usually as a disclaimer. 

Additional information is available at http://www.icmje.org/recommendations/browse/roles-and-responsibilities/author-responsibilities--conflicts-of-interest.html

MANUSCRIPT SUBMISSION

All manuscripts must be prepared according to journal instructions and submitted electronically for consideration of publication. You will find the link to the submission website from the “Instructions for Authors” page for the chosen journal. 

All manuscripts are screened for quality, structure, and plagiarism as part of the check-in process. Manuscripts may be returned without review for the following reasons: 

  • Outside scope of journal
  • Insufficient originality or novelty
  • Substantial overlap with existing publications
  • Lack of ethical clearance
  • Lack of a significant scientific merit
  • Lack of a well-articulated message
  • Incorrect format or structure
  • Extensive language or typographical errors
  • Suspected scientific misconduct

NOTE:

- Reports of clinical trials and substudies of trials must follow ICMJE guidelines in terms of registration and data sharing. Authors may also refer to http://www.icmje.org/recommendations/browse/publishing-and-editorial-issues/clinical-trial-registration.html

- Research articles and case reports involving humans must include a statement in the manuscript itself regarding ethical clearance and informed consent. If the study was exempt from ethical review, the authors should state this in the manuscript with an explanation for exemption.

All correspondence about the manuscript is sent via email from editor@innovationsjournals.org.

Manuscripts are reviewed in accordance with the peer review policy stated below. 

Use of Third-Party Material

It is the responsibility of authors/contributors to obtain permissions for reproducing any copyrighted material. Third-party material includes tables, figures, or images that have been (a) published previously or (b) provided by someone who is not an author. Authors must identify copyrighted material with an appropriate attribution to the original source and documentation of permission to reprint and/or modify the material. Sufficient documentation of permission must be provided before the article can be published. If permission is not received, the copyrighted material will be removed from the manuscript.

Protection of Research Participants

Identifying information should not be published in written descriptions, photographs, sonograms, CT scans, etc., and pedigrees unless the information is essential for scientific purposes and the patient (or parent or guardian, wherever applicable) gives informed consent for publication. Authors should remove patients' names from figures unless they have obtained informed consent from the patients. The Journals abide by ICMJE guidelines:

    1. Authors, not the Journal nor the publisher, need to obtain the patient consent form before the publication and have the form properly archived. The consent forms are not to be uploaded with the cover letter or sent through email to editorial or publisher offices.

    2. If the manuscript contains patient images that preclude anonymity, or a description that has obvious indication to the identity of the patient, a statement about obtaining informed patient consent for publication should be indicated in the manuscript.

Authors may also refer to http://www.icmje.org/recommendations/browse/roles-and-responsibilities/protection-of-research-participants.html

PEER REVIEW POLICY

Manuscripts that are considered for publication in this Journal are sent to at least two expert reviewers, with the exception of editorials, commentary, and letters, which are reviewed internally by the Editorial Team only.

During submission, the submitting author is requested to provide names of two qualified reviewers who have experience in the subject of the submitted manuscript. The suggested reviewers should not be affiliated with the same institutes as the authors. The selection of these reviewers is at the sole discretion of the editor.

The Journal follows a double-blind review process, wherein the reviewers and authors are unaware of each other’s identity. Every manuscript is also assigned to a member of the editorial team (Editor in Chief, Associate Editor, or Guest Editor) who, based on the comments from the reviewers, takes a final decision on the manuscript. The comments and suggestions (acceptance/ rejection/ amendments or revisions in manuscript) received from reviewers are conveyed to the corresponding author. If required, the author is requested to provide a point-by-point response to reviewers’ comments and submit a revised version of the manuscript. This process is repeated until the reviewers and editors are satisfied with the response and associated changes in the manuscript.

A Guest Editor is assigned in certain situations to avoid a potential conflict of interest. These situations include manuscripts authored by a member of the editorial team and manuscripts authored by individuals affiliated with the same institution as the Editor in Chief. A Guest Editor may also be assigned for manuscripts about special topics or issues outside the expertise of the editorial team.

PUBLICATION PROCESS

Manuscripts accepted for publication are copyedited for grammar, punctuation, journal style, and format. Page proofs are sent to the corresponding author. The corresponding author is expected to return the corrected proofs within 3 business days. The process of sending and receiving proofs is completed via email.

Innovations Journals publishes full manuscripts (supplemental material included) online following receipt of proof corrections and the copyright transfer form (signed by all authors). Articles may be published "ahead of print" before they are assigned to a regular volume or issue. 

Journal Fees and Access to Content

Innovations Journals does not charge fees for the submission, processing, or publication of manuscripts under the CC-BY-NC-ND license (see details below under "License and Copyright").  

The Journal does not currently charge fees for access to the content. We encourage all to register for a free subscription on our website at https://meridian.allenpress.com/innovationsjournals/pages/Subscriptions.

Advertising and Promotion

Innovations Journals offers a variety of advertising options including digital banner ads, press releases, video content, and more. Digital banner ads will rotate sequentially each time someone visits the website (these are not linked to content or reader behavior). All advertisements are subject to the Editor in Chief's approval. NOTE: The advertiser and/or advertising agency assume liability for all contents of advertising and any claims against the publisher as the result of the advertisement.

Upon acceptance of an article, the authors are encouraged to provide a one-sentence summary that can be used to announce the article on social media (along with their twitter handles). Authors are also welcome to record a brief video summary of their article that can be published on the journal's YouTube channel.

LICENSE AND COPYRIGHT

Innovations Journals are open access journals; however, the articles are distributed under the terms of the latest Creative Commons Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) License (https://creativecommons.org/licenses/by-nc-nd/4.0/) unless otherwise specified in writing. Under this license, the Journal allows authors and others to share (copy and redistribute) their work for non-commercial purposes, as long as appropriate credit is given. The Journal does not allow modifications to or commercial reuse of the work without permission from the Journal Owner (Innovative Healthcare Institute: innovativehci.com). The Journal permits authors to self-archive final accepted version of the articles on any OAI-compliant institutional/subject-based repository.

Copyright Exceptions:

  1. Authors who are college and university faculty or work for corporations should determine whether the author or institutions owns copyright for “work for hire”.
  2. If the Contribution was prepared as part of the Contributor’s official duties under a government contract or grant for the United States, United Kingdom, Canada, or Australia, then this work is within the public domain and no copyrights may be owned by the author or publisher. The respective government may reproduce, without charge, all portions of the article, and may authorize others to do so for official government purposes. Copyright assignment applies only to the extent allowable by law.

If commercial reuse of the content is required, authors may choose to have their article published under the latest CC-BY license for a fee of $300 per journal (pdf) page (https://creativecommons.org/licenses/by/4.0/). Under this license, anyone may reuse or adapt the material, including commercial reuse, as long as appropriate credit is given.

All authors are required to sign the copyright transfer form before the article can be published.

Permission to use Innovations Journals Content

For non-commerical reuse - Permission is not required to reuse or modify materials published in the Innovations Journals under the CC BY-NC-ND license; however, an appropriate citation to the original source must be included. 

For commercial reuse- Permission is required to reprint or modify material published in the Innovations Journals, and a fee may be charged, unless the content is published under the CC BY license. In general, commercial use is "primarily intended for or directed toward commercial advantage or monetary compensation." Read more at https://creativecommons.org/faq/#does-my-use-violate-the-noncommercial-clause-of-the-licenses.

All permission requests should be directed to the Publishing Manager: editor@innovationsjournals.com.

Close Modal

or Create an Account

Close Modal
Close Modal